Ferola Peter 4
4 · BIOTELEMETRY, INC. · Filed Jan 6, 2020
Insider Transaction Report
Form 4
Ferola Peter
Senior Vice President
Transactions
- Exercise/Conversion
Common Stock
2019-12-31$9.57/sh+3,433$32,854→ 13,572 total - Exercise/Conversion
Common Stock
2019-12-31$24.65/sh+1,632$40,229→ 10,139 total - Sale
Common Stock
2019-12-31$46.62/sh−5,065$236,130→ 8,507 total - Exercise/Conversion
Stock Options (Right to Buy)
2019-12-31−1,632→ 1,633 totalExercise: $24.65Exp: 2027-02-14→ Common Stock (1,632 underlying) - Exercise/Conversion
Stock Options (Right to Buy)
2019-12-31−3,433→ 0 totalExercise: $9.57Exp: 2026-02-15→ Common Stock (3,433 underlying)
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2019.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $46.25 to $46.92, inclusive. The reporting person undertakes to provide to BioTelemetry, Inc., any security holder of BioTelemetry, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- [F3]The stock options vested at the rate of 25% on each of December 31, 2017, 2018 and 2019.
- [F4]The stock options vested at the rate of 25% on each of December 31, 2016, 2017, 2018 and 2019.